Declining HIV prevalence among young pregnant women in Lusaka, Zambia Objective HIV prevention has been ongoing in Lusaka for many years. Recent reports suggest a possible decline in HIV seroincidence in Zambia and some neighbouring countries. This study aimed to examine trends in HIV seroprevalence among pregnant and parturient women between 2002 and 2006.
Methods We analysed HIV seroprevalence trends from two Lusaka sources: (i) antenatal data from a city-wide programme to prevent mother-to-child HIV transmission, and (ii) delivery data from two anonymous unlinked cord-blood surveillances performed in 2003 and again in 2005-2006 , where specimens from > 97% of public-sector births in each period were obtained and analysed. Conclusion HIV seroprevalence appears to be declining among antenatal and parturient women in Lusaka. The decline is most dramatic among women ≤ 17 years of age, suggesting a reduction in sero-incidence in this important age group.
Introduction
Lusaka is the largest city in Zambia and is among those places most heavily burdened by HIV. 1,2 Public-sector antenatal and delivery care occurs in 24 government clinics that are spread throughout the city. Each year, there are approximately 45 000 births in this system. In late 2001, the Zambian government began implementing services to prevent mother-to-child HIV transmission (PMTCT) in Lusaka and expanded this to all facilities in just over 2 years.
3 Using data available from all Lusaka public-sector obstetrical facilities, we examined trends in HIV seroprevalence among pregnant and parturient women between 2002 and 2006.
Methods

Data sources
We examined data from two sources. The first comprised routinely collected PMTCT data from the Lusaka Urban Health District. In 2002, nine clinics were offering PMTCT services. By January 2004, all clinics were covered. For this analysis, we used data collected between July 2002 and December 2006 from public-sector clinics offering PMTCT. Routine indicators collected at these facilities include: number of new antenatal attendees, number of women counselled for HIV testing, number of women tested for HIV, number of women with positive test results, and numbers of women and infants receiving antiretroviral prophylaxis for PMTCT. These indicators are collected in facility-based log books and aggregated periodically for government reporting. Age data are not routinely collected.
The second data source comes from two anonymous cord-blood surveillance exercises performed in Lusaka to evaluate the effectiveness of PMTCT services. Details of the surveillance methodology have been described elsewhere. 4 Since maternal IgG (gamma globulin) anti-HIV antibodies cross the placenta freely throughout pregnancy, seropositivity of umbilical-cord blood indicates maternal HIV infection. 
Analysis
Programmatic data on HIV prevalence were aggregated over periods of 3 months to provide stability for individual period estimates. We used the Cochran-Armitage test to evaluate the trend in HIV prevalence over time and used logistic regression to produce predicted probabilities of maternal HIV-positive status over the course of the programme. Since HIV-prevalence rates may vary geographically, and not all sites had PMTCT services until the beginning of 2004, we also evaluated site-specific estimates by examining each site separately over time and by employing generalized linear mixed models with random coefficient analysis.
5
For analysis of the cord-blood surveillances, we restricted the data to women who received their antenatal care in Lusaka to maximize comparability with the antenatal data. We used the c² test to compare HIV prevalence rates (overall and stratified by age) between the two surveillance exercises. We used Wilson's method 6 to generate confidence intervals around prevalence estimates in both the programmatic data and the cord-blood surveillance. Analyses were performed with SAS 9.1 (SAS Institute, Cary, NC, USA) and S-Plus 6.1 (Insightful Corporation, Seattle, WA, USA.).
Results
Programmatic PMTCT data
From July 2002 to December 2006, the proportion of women attending antenatal care clinics who accepted HIV testing increased steadily over the evaluation period (71% to 94%; P < 0.001; Fig. 1 These site-specific declines were statistically significant (P < 0.05) in 11 sites. In three sites, the trend was slightly positive, but did not achieve statistical significance. The generalized linear mixed models with random coefficients analysis estimated the average decline in the site-specific HIV prevalence rates of about 1% per year (0.988%, P < 0.001). This rate of decline is slightly greater than that estimated by the logistical model, which does not consider site variation in its estimate (Fig. 2) .
Cord-blood surveillance data 
Discussion
These data clearly indicate a decline in HIV seroprevalence among pregnant women in Lusaka between 2002 and 2006. The most notable decline occurred among the youngest women (≤ 17 years of age). HIV in this age group declined from 12.1% to 7.7% over a 28-month period. HIV prevalence among adolescents has been proposed as a reasonable surrogate for HIV incidence since this population can be presumed to have become sexually active recently. Use of HIV seroprevalence among adolescents to estimate incidence is particularly useful in settings where more accurate measures of HIV incidence (e.g. detuned antibody assays, pooled RNA testing) are not yet part of widespread surveillance activities. 7 Other investigators in Zambia corroborate our findings with notable declines in the youngest age groups and in Lusaka in general. 8, 9 The primary strength of this analysis lies in the very high ascertainment Research HIV prevalence among pregnant women in Zambia Elizabeth M Stringer et al. (N Chintu, unpublished) . We also know from the cord-blood surveillances that women who refused testing in 2003 were more likely to be seropositive than those who accepted. 4 In light of this, it is likely that the decline in seroprevalence represented by the regression line in Fig. 2 may actually under-represent the real decline.
Since these data derive from populations of pregnant women, we should be careful not to make broad generalizations about HIV trends among all adolescents or all women. However, we would anticipate that the HIV seroprevalence among pregnant adolescents would be higher than among adolescents in the general population. In the oldest age groups of women, the HIV seroprevalence declined only modestly or not at all. This may represent a cohort effect, where HIVinfected women become older between sampling periods and move from one age group to another, but also, we suspect that the slight decline in the older populations may be due to death of infected women. 4 As highly active antiretroviral therapy becomes more widespread, and there are potentially fewer people dying from AIDS, we might expect over time that the overall HIV seroprevalence would increase in the older populations.
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With over 37 million adults infected worldwide, and 5.3 million new cases each year, the ultimate solution to the epidemic is to prevent new cases of HIV, especially among young people. Ecological data from Uganda suggest that prevention campaigns are working: condom usage and preventive sexual behaviour has increased simultaneously as the HIV prevalence among the antenatal population has continued to decline.
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Résumé Déclin de la prévalence du VIH chez les jeunes femmes enceintes de Lusaka en Zambie
Objectif La prévention de l'infection par le VIH est pratiquée à Lusaka depuis de nombreuses années. Les rapports récents laissent entrevoir un déclin de la séroincidence du VIH en Zambie et dans certains pays voisins. L'objectif de la présente étude est d'examiner les tendances de la séroprévalence du VIH chez les femmes enceintes et les parturientes entre 2002 et 2006.
Resumen Disminución de la prevalencia de VIH entre embarazadas jóvenes en Lusaka, Zambia
Objetivo Desde hace ya muchos años se aplican en Lusaka medidas de prevención de la infección por VIH. Algunos datos recientes parecen indicar que se ha producido una disminución de la seroincidencia de VIH en Zambia y en algunos países vecinos. 
